Skip to main content
Top
Published in: Clinical Research in Cardiology 5/2015

01-05-2015 | Original Paper

Safety and efficacy of external electrical cardioversion in patients with left ventricular leads

Authors: Jakob Lüker, Georg von Bodman, Arian Sultan, Jürgen Brömsen, Ruken Ö. Akbulak, Benjamin Schäffer, Doreen Schreiber, Boris A. Hoffmann, Michael Block, Stephan Willems, Daniel Steven

Published in: Clinical Research in Cardiology | Issue 5/2015

Login to get access

Abstract

Background

Atrial arrhythmias lower the biventricular pacing percentage in cardiac resynchronization therapy (CRT) treated patients (pts) and have a high prevalence in this population. External electrical cardioversion (ECV) is commonly performed to restore sinus rhythm. There is a paucity of data on the safety and efficacy of ECV in pts with CRT devices.

Methods

Forty-three pts with CRT devices undergoing ECV at two centers were included prospectively. Devices were interrogated immediately prior to and after ECV, as well as after 4 weeks.

Results

Devices (CRT-D in 38 and CRT-P in 5) were all implanted in left pectoral position, with predominantly bipolar left ventricular (LV) leads. Sixty-one shocks were delivered, all biphasic. Arrhythmia had recurred in 36 % of pts at follow-up (FU). There was a significant increase in LV lead threshold voltage and drop in bipolar LV lead impedance after ECV, which returned to normal at FU. An at least twofold increase in pacing threshold voltage at FU was seen in 2 LV leads and a 0.5 V increase in threshold in 3 LV leads. Overall, biventricular pacing significantly increased during FU.

Conclusion

ECV in CRT pts was safe and effective in this two-center study. A transient increase in LV lead pacing threshold was observed. Relevant changes in pacing threshold at FU occurred in five LV leads—identification and regular FU of these pts are necessary. Restoring SR through ECV significantly increased the biventricular pacing percentage but arrhythmia recurrence was frequent. CRT pts with atrial arrhythmias require close FU after ECV.
Literature
1.
go back to reference Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338CrossRefPubMed Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338CrossRefPubMed
2.
go back to reference Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395CrossRefPubMed Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395CrossRefPubMed
3.
go back to reference Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329CrossRefPubMed Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329CrossRefPubMed
4.
go back to reference Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100 % biventricular pacing necessary? J Am Coll Cardiol 53:355–360CrossRefPubMed Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100 % biventricular pacing necessary? J Am Coll Cardiol 53:355–360CrossRefPubMed
5.
go back to reference Hayes DL, Boehmer JP, Day JD, Gilliam FR, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475CrossRefPubMed Hayes DL, Boehmer JP, Day JD, Gilliam FR, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475CrossRefPubMed
6.
go back to reference Cheng A, Landman SR, Stadler RW (2012) Reasons for loss of cardiac resynchronization therapy pacing: insights from 32,844 patients. Circ Arrhythm Electrophysiol 5:884–888CrossRefPubMed Cheng A, Landman SR, Stadler RW (2012) Reasons for loss of cardiac resynchronization therapy pacing: insights from 32,844 patients. Circ Arrhythm Electrophysiol 5:884–888CrossRefPubMed
7.
go back to reference Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ (2014) The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter–defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 63:1190–1197CrossRefPubMed Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ (2014) The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter–defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 63:1190–1197CrossRefPubMed
8.
go back to reference Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL (2014) The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 7:370–376CrossRefPubMed Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL (2014) The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 7:370–376CrossRefPubMed
9.
go back to reference Lown B, Neuman J, Amarasingham R, Berkovits BV (1962) Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 10:223–233CrossRefPubMed Lown B, Neuman J, Amarasingham R, Berkovits BV (1962) Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 10:223–233CrossRefPubMed
10.
go back to reference Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 33(21):2719–2747CrossRefPubMed Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 33(21):2719–2747CrossRefPubMed
11.
go back to reference January CT, Wann LS, Alpert JS, et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation January CT, Wann LS, Alpert JS, et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation
12.
go back to reference Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422CrossRefPubMed Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422CrossRefPubMed
13.
go back to reference Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168CrossRefPubMed Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168CrossRefPubMed
14.
go back to reference Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198CrossRefPubMed Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198CrossRefPubMed
15.
go back to reference Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter–defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738CrossRefPubMed Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter–defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738CrossRefPubMed
16.
go back to reference Tracy CM, Akhtar M, DiMarco JP, Heart Rhythm Society et al (2006) American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on clinical competence and training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 48:1503–1517CrossRefPubMed Tracy CM, Akhtar M, DiMarco JP, Heart Rhythm Society et al (2006) American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on clinical competence and training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 48:1503–1517CrossRefPubMed
17.
go back to reference Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263CrossRef Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263CrossRef
18.
go back to reference Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M (2002) Anterior–posterior versus anterior–lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360:1275–1279CrossRefPubMed Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M (2002) Anterior–posterior versus anterior–lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360:1275–1279CrossRefPubMed
19.
go back to reference Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677CrossRefPubMed Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677CrossRefPubMed
20.
go back to reference Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894–1903CrossRefPubMed Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894–1903CrossRefPubMed
21.
go back to reference Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726CrossRefPubMed Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726CrossRefPubMed
Metadata
Title
Safety and efficacy of external electrical cardioversion in patients with left ventricular leads
Authors
Jakob Lüker
Georg von Bodman
Arian Sultan
Jürgen Brömsen
Ruken Ö. Akbulak
Benjamin Schäffer
Doreen Schreiber
Boris A. Hoffmann
Michael Block
Stephan Willems
Daniel Steven
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 5/2015
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-014-0800-5

Other articles of this Issue 5/2015

Clinical Research in Cardiology 5/2015 Go to the issue